Acquired resistance to the RAS(ON) multi-selective inhibitor daraxonrasib guides rational combination therapy strategies in pancreatic cancer. (nature.com)

Authors: Aronchik I … Singh M Journal: Nature Medicine Published: 2026-08-11 DOI: https://doi.org/10.1038/s41591-026-04537-w